VoICE Immunization Evidence: Antibiotic Resistance
Antimicrobial-resistant infections are expensive to treat and place an economic burden on families and health systems.
Key Evidence: The US CDC estimates that antibiotic resistant pneumococcal infections in the US add $96 million to the costs of treatment each year.
Centers for Disease Control and Prevention 2013. Antibiotic resistance threats in the United States, 2013 (Report).